FASTER DRUG
DISCOVERY

3Z incorporates the latest advances in disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders.

RESEARCH

Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing licensed drugs for new medical indications.

PRESS RELEASES

3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling

August 18, 2023

3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform

June 20, 2022

We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our unique, behaviour based zebrafish screening technology.

ZEBRAFISH SCREENING

WHO WE ARE

An innovative company which uses zebrafish to screen for neurologically effective drugs which are highly appropriate for drug repurposing.

OUR METHOD

About 3 year faster market entry, since approval could refer to existing publications and approval data from originator.

FASTER DRUG DISCOVERY